ABOUT BORA PHARMACEUTICALS

Who We Are

Bora Pharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in complex oral solid dosage (tablet & capsules), biologicsliquids (solutions, suspensions, ophthalmics & nasal sprays), powders,  semi-solids (creams, ointments & gels), and sterile injectables for pharmaceutical products for Clinical through Commercial manufacturing and packaging.

Global Presence

Bora owns and operates ten state-of-the-art cGMP manufacturing facilities (Taiwan, Canada, and the US) built to the highest international standards for manufacturing, packaging, R&D, and analytical testing. From these facilities we deliver to more than 100 marketings around the world.

Our Taiwanese facilities are USFDA, MHRA, TFDA, Jordan FDA, and GCC (Gulf Cooperation Council) inspected.  Our Mississauga, Canada site is approved by all major regulatory agencies including USFDA, Health Canada, ANVISA, EMEA, PDMA, and the Japanese Ministry of Health.  Our last FDA audits have had no 483s.

Commitment to quality

At Bora, we have never compromised on quality, and we never will.

All our manufacturing operations have maintained positive compliance records with many of the world’s leading regulatory agencies, confirming our framework to provide high-quality drug and consumer products.

We operate advanced, electronic quality systems in our laboratories, production areas, quality assurance department, and day-to-day operations and business, thus ensuring Bora’s operational teams have the tools they need to provide the highest levels of proactive and sustainable manufacturing quality.

Bora Pledge

As a future focused CDMO, we know better than most that our own success is shaped by our partners victories. That’s why, when you choose Bora – we make success more certain by following Bora’s 5Ps – Promises, Partnerships, Pride, People, and Progress. 

These 5 principles are Bora’s Pledge to our customers.

People

Investing in the best

As an organization, you’re only as good as your people. As a CDMO with ambitious goals, our culture and the caliber of those who represent us is something we must take more seriously than most. For us, success really is personal!

 

Partnerships

Succeeding with you

With so much on the line, reliable, sustainable partnerships are as important to us as they are to those we work with. Where many CDMOs seem to favor short-term wins, we commit our energies to creating long-term, strategic relationships where success is achieved together.

 

Promises

Committing to our word

In an industry of uncertainty, there’s absolutely no room for broken promises. Yet, too many CDMOs promise too much, deliver less, and miss deadlines, thereby, eroding confidence and trust. At Bora Pharmaceuticals, we are determined to put this right. When we make promises we keep them, it’s as simple as that.

Pride

Uncompromising about quality

As a business and as people, we take immense pride in what we do. We have to. It’s only by pursuing a deep satisfaction in the quality of our product, the services we’ve provided, or the experience we’ve created that we can be more certain of mutual success.

Progress

Building for the future

Unprecedented regulations, advances, and changes affect today’s pharmaceutical industry, and only the most progressive CDMOs will thrive. At Bora Pharmaceuticals, we’re set on building a business and culture fit for the future. One that’s perpetually enhancing capability and expertise, seeking continuous improvement, and evolving with the long-term needs of our customers.

CONTACT INFORMATION

Bora Pharmaceuticals

7333 Mississauga Rd.

Mississauga, L5N 6L4

CANADA

Phone: 1-844-626-7846

Contact: Anna Hogan, Senior Director Global Marketing

LINKEDIN

A premier international CDMO, making success more certain.

https://www.linkedin.com/company/borapharmaceuticals

FEATURED ARTICLES

FEATURED SERVICES

FEATURED VIDEOS

From world-class facilities across North America and Asia, high-quality drug products are manufactured and supplied to over 100 global markets, supporting patient and healthcare needs.

Tara Lorenz, Sr. Director of Commercial Operations, speaks on our latest investments and expanded fill/finish capabilities and capacity for small molecules, biologics, and other sterile injectable products.

Specializing in formulation development, clinical and commercial manufacturing, and advanced packaging solutions, we bring expertise across a diverse range of dosage forms.

FEATURED BROCHURES